key: cord-0936054-p33v5fwc
authors: Bøhler, Anders Djupesland; Strøm, Marianne Ekornes; Sandvig, Kjell Ulrik; Moe, Morten Carstens; Jørstad, Øystein Kalsnes
title: Acute macular neuroretinopathy following COVID-19 vaccination
date: 2021-06-22
journal: Eye (Lond)
DOI: 10.1038/s41433-021-01610-1
sha: 077aeb46d025d42503d0b5816e975b572b3d709c
doc_id: 936054
cord_uid: p33v5fwc

nan

contraceptive (combined desogestrel and ethinylestradiol). As she worked in a hospital, she had been prioritised for COVID-19 vaccination and had recently received the first dose of the AstraZeneca vaccine. The same day she developed flu-like symptoms. These resolved 2 days later. However, a left paracentral scotoma appeared at this point.

On clinical examination the best-corrected visual acuity was 20/20 in both eyes. Threshold perimetry of the left eye showed a modest paracentral scotoma in the upper temporal quadrant. The intraocular pressure was normal in both eyes, and there were no signs of intraocular inflammation. Fundoscopy of the left eye revealed a delicate teardrop-shaped macular lesion nasally to the fovea ( Fig. 1) , which was visualised better on swept source optical coherence tomography (SS-OCT) en face images ( Fig. 2A) . Crosssectional SS-OCT of the lesion demonstrated slight hyperreflectivity of the outer nuclear and plexiform layers and disruption of the ellipsoid zone (Fig. 2B) . SS-OCT angiography indicated subtle dropout in the deep capillary plexus corresponding to the lesion (Fig. 2C) . There was no evidence of VITT; laboratory work-up showed a normal complete blood count, negative C-reactive protein and absence of antibodies to platelet factor 4-polyanion complexes.

The signs and symptoms of our patient were consistent with acute macular neuroretinopathy (AMN). The exact pathophysiology of AMN is unknown, but several risk factors have been identified; the most common associations are non-specific flu-like illness or fever and use of oral contraceptives [1] . The present case further expands the spectrum of possible associations. To the best of our knowledge, AMN following COVID-19 vaccination has not been previously published, and a coincidental finding cannot be ruled out. However, there are case reports of AMN in the course of COVID-19 infection [2] [3] [4] . An association between AMN and both COVID-19 infection and vaccination raises the question as to whether a common immune-mediated pathway can trigger this peculiar macular disease. 

Acute macular neuroretinopathy: a comprehensive review of the literature

Paracentral acute middle maculopathy and acute macular neuroretinopathy following SARS-CoV-2 infection

Covid-19-associated retinopathy: a case report

Acute macular neuroretinopathy in a patient with acute myeloid leukemia and deceased by COVID-19: a case report

The authors wish to thank Dr Ingvild Hausberg Sørvoll for performing the antibody analysis.

Correspondence and requests for materials should be addressed to A.D.Bøh.Reprints and permission information is available at http://www.nature.com/ reprintsPublisher's note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.